Evidence map›Paper›PMID 41282932›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Virtual Neuronavigation for Parcel-guided TMS.

Dennis Q Truong, Abhishek Datta, Jeffrey Moreno, Yishai Z Valter, Rashel Mejia, Kamran Nazim, Yifan Gao, Yu Huang, Joshua A Berman, Daniel C Javitt

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dennis Q TruongResearch and Development, Soterix Medical, Inc, Woodbridge, NJ.ORCID 0000-0003-2906-3892
Abhishek DattaResearch and Development, Soterix Medical, Inc, Woodbridge, NJ.ORCID 0000-0002-6778-8125
Jeffrey MorenoResearch and Development, Soterix Medical, Inc, Woodbridge, NJ.
Yishai Z ValterResearch and Development, Soterix Medical, Inc, Woodbridge, NJ.ORCID 0000-0002-6131-1166
Rashel MejiaColumbia University, New York, NY.ORCID 0009-0001-2197-7377
Kamran NazimResearch and Development, Soterix Medical, Inc, Woodbridge, NJ.
Yifan GaoColumbia University, New York, NY.ORCID 0000-0003-3976-6364
Yu HuangResearch and Development, Soterix Medical, Inc, Woodbridge, NJ.ORCID 0000-0003-4178-0739
Joshua A BermanColumbia University, New York, NY.
Daniel C JavittColumbia University, New York, NY.ORCID 0000-0003-2711-8239

Funding

Virtual neuro-navigation system for personalized,community-based TMSR44MH126833 · NIMH · SOTERIX MEDICAL,INC. · PI TRUONG, DENNIS QUANGVINH · 2021 to 2023
$957k
NIMH NIH HHS R44 MH126833
6 · The paper itself

Abstract

Background: rTMS for depression is partially effective which is likely in part due to the treatment coil positioning being based on scalp-based approaches. Such an approach results in not accounting for Methods: We sought to develop a virtual neuronavigation system in which MRI images are processed on the backend to determine p46 and a corresponding individualized 3D printed scalp headgear is developed. The headgear includes markings for the location corresponding to p46 and other anatomical guides. Headgear development involved an iterative sequence of 3D CAD modeling, printing, and testing to meet the gold standard neuronavigation-guided location. Individual headgear accuracy is then verified by positioning on the intended subject and comparing alignment with the location on the scalp and brain intersecting the neuronavigation beam targeting p46. Reproducibility testing was also performed. Results: Across 16 test subjects on which the final version of the headgear could be tested, individualized headgear was found to be 8.31± 4.93 mm from the neuronavigation-determined scalp location. The corresponding distances on the brain was 7.94± 4.99 mm. Within-subject reproducibility (against centroid formed by 3 measurements) was 1.21 ± 0.84 mm across n= 8 subjects. Conclusion: Individualized headgear targeting presents a viable option for practices to leverage state-of-the-art targeting advances without investing in neuronavigation hardware.

Indexed as

coil positioningHCP atlasindividualized positioningneuronavigationrTMS for depressiontreatment resistant depression

Identifiers

PMID41282932
PMCPMC12633095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.